Longevity Fund
Venture Capital
Active
San Francisco, United States
22
29M
17
1.69
0.23
4
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the San Francisco. The company was established in North America in United States.
The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight ALX Oncology, Decibel Therapeutics, Fauna Bio. Among the most popular fund investment industries, there are Content Discovery, Health Care.
The fund is generally included in 2-6 deals every year. The top activity for fund was in 2018. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2019. Opposing the other organizations, this The Longevity Fund works on 7 percentage points less the average amount of lead investments.
The current fund was established by Laura Deming. Besides them, we counted 1 critical employee of this fund in our database.
The usual cause for the fund is to invest in rounds with 9-10 partakers. Despite the The Longevity Fund, startups are often financed by Venrock, General Catalyst, Elad Gil. The meaningful sponsors for the fund in investment in the same round are General Catalyst, Elad Gil, Caffeinated Capital. In the next rounds fund is usually obtained by General Catalyst, Elad Gil, Caffeinated Capital.
Investor highlights
- Industry focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 35000000
- Fund raised date
- 2023-09-21
Analytics
- Total investments
- 22
- Lead investments
- 0
- Exits
- 4
- Rounds per year
- 1.69
- Follow on index
- 0.23
- Investments by industry
- Biotechnology (18)
- Health Care (16)
- Medical (6)
- Life Science (5)
- Biopharma (4) Show 18 more
- Investments by region
-
- United States (20)
- Israel (2)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 11M
- Group Appearance index
- 1.00
- Avg. company exit year
- 4
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| CoDot | 10 Mar 2022 | Artificial Intelligence, Social Media, Media and Entertainment, Professional Networking, Dating, Audiobooks | Seed | 78K | Bangalore, Karnataka, India |
| EDocate | 29 Apr 2021 | Health Care, EdTech, Training, Education, Ediscovery | Seed | 3M | Tel Aviv District, Tel Aviv-Yafo, Israel |
| Fauna Bio | 11 Apr 2019 | Biotechnology, Health Care, Hospital, Medical | Seed | 4M | United States, California, Berkeley |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.